Abstract
Purpose of Review
The perinatal period is a time of increased vulnerability for people with bipolar disorder (BD). The purpose of this review is to provide an update of the literature from the last 3 years regarding course of illness and treatments for BD in the perinatal period to guide clinical care.
Recent Findings
Postpartum manic and depressive episodes are emerging as having a unique presentation that may differentiate them from non-perinatal mood episodes. Many important updates regarding medication treatment in the perinatal period have been published recently that have considered the risks of untreated illness versus treatment risks in this population.’
Summary
Despite significant research, there are still gaps in knowledge regarding safety and efficacy of medications for the mother and child. Crucial future areas of study include improved screening guidelines, randomized controlled trials examining medication safety in pregnancy and lactation, and efficacy of nonpharmacologic treatments.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as:
• Of importance
•• Of major importance
Hernandez-Diaz S, Huybrechts KF, Desai RJ, Cohen JM, Mogun H, Pennell PB, et al. Topiramate use early in pregnancy and the risk of oral clefts: a pregnancy cohort study. Neurology. 2018;90(4):e342–51. https://doi.org/10.1212/WNL.0000000000004857.
Khan SJ, Fersh ME, Ernst C, Klipstein K, Albertini ES, Lusskin SI. Bipolar disorder in pregnancy and postpartum: principles of management. Curr Psychiatry Rep. 2016;18(2):13. https://doi.org/10.1007/s11920-015-0658-x.
Kendall-Tackett KA. Depression in new mothers: causes, consequences, and treatment alternatives. New York: The Haworth Maltreatment and Trauma Press. 2005.
Simeonova DI, Attalla AM, Nguyen T, Stagnaro E, Knight BT, Craighead WE, et al. Temperament and behavior in toddlers of mothers with bipolar disorder: a preliminary investigation of a population at high familial risk for psychopathology. J Child Adolesc Psychopharmacol. 2014;24(10):543–50. https://doi.org/10.1089/cap.2013.0136.
Schechter JC, Brennan PA, Smith AK, Stowe ZN, Newport DJ, Johnson KC. Maternal prenatal psychological distress and preschool cognitive functioning: the protective role of positive parental engagement. J Abnorm Child Psychol. 2017;45(2):249–60. https://doi.org/10.1007/s10802-016-0161-9.
Patorno E, Huybrechts KF, Bateman BT, Cohen JM, Desai RJ, Mogun H, et al. Lithium use in pregnancy and the risk of cardiac malformations. N Engl J Med. 2017;376(23):2245–54. https://doi.org/10.1056/NEJMoa1612222.
Wesseloo R, Kamperman AM, Munk-Olsen T, Pop VJ, Kushner SA, Bergink V. Risk of postpartum relapse in bipolar disorder and postpartum psychosis: a systematic review and meta-analysis. Am J Psychiatry. 2016;173(2):117–27. https://doi.org/10.1176/appi.ajp.2015.15010124.
Viguera AC, Whitfield T, Baldessarini RJ, Newport DJ, Stowe Z, Reminick A, et al. Risk of recurrence in women with bipolar disorder during pregnancy: prospective study of mood stabilizer discontinuation. Am J Psychiatry. 2007;164(12):1817–24; quiz 923. https://doi.org/10.1176/appi.ajp.2007.06101639.
Nora JJ, Nora AH, Toews WH. Letter: Lithium, Ebstein’s anomaly, and other congenital heart defects. Lancet. 1974;2(7880):594–5. https://doi.org/10.1016/s0140-6736(74)91918-7.
Newport DJ, Viguera AC, Beach AJ, Ritchie JC, Cohen LS, Stowe ZN. Lithium placental passage and obstetrical outcome: implications for clinical management during late pregnancy. Am J Psychiatry. 2005;162(11):2162–70. https://doi.org/10.1176/appi.ajp.162.11.2162.
Troyer WA, Pereira GR, Lannon RA, Belik J, Yoder MC. Association of maternal lithium exposure and premature delivery. J Perinatol. 1993;13(2):123–7.
Yatham LN, Kennedy SH, Parikh SV, Schaffer A, Bond DJ, Frey BN, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder. Bipolar Disord. 2018;20(2):97–170. https://doi.org/10.1111/bdi.12609.
Di Florio A, Forty L, Gordon-Smith K, Heron J, Jones L, Craddock N, et al. Perinatal episodes across the mood disorder spectrum. JAMA Psychiat. 2013;70(2):168–75. https://doi.org/10.1001/jamapsychiatry.2013.279.
Clark CT, Sit DK, Driscoll K, Eng HF, Confer AL, Luther JF, et al. Does screening with the Mdq and Epds improve identification of bipolar disorder in an obstetrical sample? Depress Anxiety. 2015;32(7):518–26. https://doi.org/10.1002/da.22373.
Sharma V, Doobay M, Baczynski C. Bipolar postpartum depression: an update and recommendations. J Affect Disord. 2017;219:105–11. https://doi.org/10.1016/j.jad.2017.05.014.
Koukopoulos AE, Angeletti G, Sani G, Janiri D, Manfredi G, Kotzalidis GD, et al. Perinatal mixed affective state: wherefore art thou? Psychiatr Clin North Am. 2020;43(1):113–26. https://doi.org/10.1016/j.psc.2019.10.004.
Diagnostic and statistical manual of mental disorders. 5th ed. Arlington, VA: American Psychiatric Publishing; 2013.
Newport DJ, Baldessarini RJ, Knight BT, Fernandez SV, Morris NJ, Viguera AC, et al. Comparison of women with confirmed versus presumably misdiagnosed bipolar disorder. J Clin Psychiatry. 2012;73(2):242–6. https://doi.org/10.4088/JCP.11m06936.
Gynecologists ACoOa. ACOG committee opinion No. 757: Screening for perinatal depression. Obstet Gynecol. 2018;132(5):e208-e12. https://doi.org/10.1097/AOG.0000000000002927.
Hirschfeld RM, Williams JB, Spitzer RL, Calabrese JR, Flynn L, Keck PE Jr, et al. Development and validation of a screening instrument for bipolar spectrum disorder: the mood disorder questionnaire. Am J Psychiatry. 2000;157(11):1873–5. https://doi.org/10.1176/appi.ajp.157.11.1873.
Masters GA, Brenckle L, Sankaran P, Person SD, Allison J, Moore Simas TA, et al. Positive screening rates for bipolar disorder in pregnant and postpartum women and associated risk factors. Gen Hosp Psychiatry. 2019;61:53–9. https://doi.org/10.1016/j.genhosppsych.2019.09.002.
• Gordon-Smith K, Perry A, Di Florio A, Forty L, Fraser C, Casanova Dias M, et al. Symptom profile of postpartum and non-postpartum manic episodes in bipolar I disorder: a within-subjects study. Psychiatry Res. 2020;284: 112748. https://doi.org/10.1016/j.psychres.2020.112748. A well-designed retrospective study demonstrating differences in manic episodes during the postpartum period than mania at other times of the same woman’s bipolar illness.
Lewis KJS, Di Florio A, Forty L, Gordon-Smith K, Perry A, Craddock N, et al. Mania triggered by sleep loss and risk of postpartum psychosis in women with bipolar disorder. J Affect Disord. 2018;225:624–9. https://doi.org/10.1016/j.jad.2017.08.054.
•• Tebeka S, Godin O, Mazer N, Bellivier F, Courtet P, Etain B, et al. Clinical characteristics of bipolar disorders with postpartum depressive onset. Prog Neuropsychopharmacol Biol Psychiatry. 2021;107:110225. https://doi.org/10.1016/j.pnpbp.2020.110225. This is the first known study to demonstrate less severe BD illness when the first mood episode is a postpartum bipolar depressive episode.
Sharma V, Xie B, Campbell MK, Penava D, Hampson E, Mazmanian D, et al. A prospective study of diagnostic conversion of major depressive disorder to bipolar disorder in pregnancy and postpartum. Bipolar Disord. 2014;16(1):16–21. https://doi.org/10.1111/bdi.12140.
Liu X, Agerbo E, Li J, Meltzer-Brody S, Bergink V, Munk-Olsen T. Depression and anxiety in the postpartum period and risk of bipolar disorder: a Danish nationwide register-based cohort study. J Clin Psychiatry. 2017;78(5):e469–76. https://doi.org/10.4088/JCP.16m10970.
Rowland TA, Marwaha S. Epidemiology and risk factors for bipolar disorder. Ther Adv Psychopharmacol. 2018;8(9):251–69. https://doi.org/10.1177/2045125318769235.
Felitti VJ, Anda RF, Nordenberg D, Williamson DF, Spitz AM, Edwards V, et al. Relationship of childhood abuse and household dysfunction to many of the leading causes of death in adults. The Adverse Childhood Experiences (ACE) Study. Am J Prev Med. 1998;14(4):245–58. https://doi.org/10.1016/s0749-3797(98)00017-8.
Perry A, Gordon-Smith K, Di Florio A, Fraser C, Craddock N, Jones L, et al. Adverse childhood experiences and postpartum depression in bipolar disorder. J Affect Disord. 2020;263:661–6. https://doi.org/10.1016/j.jad.2019.11.042.
Park Y-M, Shekhtman T, Kelsoe JR. Effect of the type and number of adverse childhood experiences and the timing of adverse experiences on clinical outcomes in individuals with bipolar disorder. Brain Sci. 2020;10(5):254. https://doi.org/10.3390/brainsci10050254.
Guintivano J, Sullivan PF, Stuebe AM, Penders T, Thorp J, Rubinow DR, et al. Adverse life events, psychiatric history, and biological predictors of postpartum depression in an ethnically diverse sample of postpartum women. Psychol Med. 2018;48(7):1190–200. https://doi.org/10.1017/S0033291717002641.
Kettunen P, Hintikka J. Psychosocial risk factors and treatment of new onset and recurrent depression during the post-partum period. Nord J Psychiatry. 2017;71(5):355–61. https://doi.org/10.1080/08039488.2017.1300324.
Plaza A, Garcia-Esteve L, Torres A, Ascaso C, Gelabert E, Luisa Imaz M, et al. Childhood physical abuse as a common risk factor for depression and thyroid dysfunction in the earlier postpartum. Psychiatry Res. 2012;200(2–3):329–35. https://doi.org/10.1016/j.psychres.2012.06.032.
Sharma V, Bergink V, Berk M, Chandra PS, Munk-Olsen T, Viguera AC, et al. Childbirth and prevention of bipolar disorder: an opportunity for change. Lancet Psychiatry. 2019;6(9):786–92. https://doi.org/10.1016/S2215-0366(19)30092-6.
Di Florio A, Gordon-Smith K, Forty L, Kosorok MR, Fraser C, Perry A, et al. Stratification of the risk of bipolar disorder recurrences in pregnancy and postpartum. Br J Psychiatry. 2018;213(3):542–7. https://doi.org/10.1192/bjp.2018.92.
Vichi M, Berardelli I, Pompili M. Completed suicide during pregnancy and postpartum. Ann Ist Super Sanita. 2021;57(1):57–66. https://doi.org/10.4415/ANN_21_01_09.
Mangla K, Hoffman MC, Trumpff C, O’Grady S, Monk C. Maternal self-harm deaths: an unrecognized and preventable outcome. Am J Obstet Gynecol. 2019;221(4):295–303. https://doi.org/10.1016/j.ajog.2019.02.056.
Sole E, Torres A, Roca A, Hernandez AS, Roda E, Sureda B, et al. Obstetric complications in bipolar disorder: the role of mental health disorders in the risk of caesarean section. J Affect Disord. 2019;252:458–63. https://doi.org/10.1016/j.jad.2019.04.017.
Sole E, Roca A, Torres A, Hernandez AS, Fernandez N, Diaz CN, et al. Obstetric complications in bipolar disorder: psychiatric factors and the risk of caesarean section. Eur Neuropsychopharmacol. 2020;32:47–55. https://doi.org/10.1016/j.euroneuro.2019.12.115.
Wisner KL, Sit D, O’Shea K, Bogen DL, Clark CT, Pinheiro E, et al. Bipolar disorder and psychotropic medication: impact on pregnancy and neonatal outcomes. J Affect Disord. 2019;243:220–5. https://doi.org/10.1016/j.jad.2018.09.045.
Park Y, Hernandez-Diaz S, Bateman BT, Cohen JM, Desai RJ, Patorno E, et al. Continuation of atypical antipsychotic medication during early pregnancy and the risk of gestational diabetes. Am J Psychiatry. 2018;175(6):564–74. https://doi.org/10.1176/appi.ajp.2018.17040393.
• Fornaro M, Maritan E, Ferranti R, Zaninotto L, Miola A, Anastasia A, et al. Lithium exposure during pregnancy and the postpartum period: a systematic review and meta-analysis of safety and efficacy outcomes. Am J Psychiatry. 2020;177(1):76–92. https://doi.org/10.1176/appi.ajp.2019.19030228. This is a systematic review and meta-analysis that summarized safety data for lithium use during pregnancy, comparing lithium-exposed versus unexposed women with mood disorders.
Reinstein SA, Cosgrove J, Malekshahi T, Deligiannidis KM. Long-acting injectable antipsychotic use during pregnancy: a brief review and concise guide for clinicians. J Clin Psychiatry. 2020;81(6). https://doi.org/10.4088/JCP.20ac13597.
Clark CT, Wisner KL. Treatment of peripartum bipolar disorder. Obstet Gynecol Clin North Am. 2018;45(3):403–17. https://doi.org/10.1016/j.ogc.2018.05.002.
Freeman MP, Viguera AC, Goez-Mogollon L, Young AV, Caplin PS, McElheny SA, et al. Reproductive safety of aripiprazole: data from the Massachusetts General Hospital National Pregnancy Registry for Atypical Antipsychotics. Arch Womens Ment Health. 2021. https://doi.org/10.1007/s00737-021-01115-6.
Cuomo A, Goracci A, Fagiolini A. Aripiprazole use during pregnancy, peripartum and lactation. A systematic literature search and review to inform clinical practice. J Affect Disord. 2018;228:229–37. https://doi.org/10.1016/j.jad.2017.12.021.
Freeman MP, Sosinsky AZ, Goez-Mogollon L, Savella GM, Moustafa D, Viguera AC, et al. Gestational weight gain and pre-pregnancy body mass index associated with second-generation antipsychotic drug use during pregnancy. Psychosomatics. 2018;59(2):125–34. https://doi.org/10.1016/j.psym.2017.09.002.
Dragoi AM, Radulescu I, Nasui BA, Pop AL, Varlas VN, Trifu S. Clozapine: an updated overview of pharmacogenetic biomarkers, risks, and safety-particularities in the context of COVID-19. Brain Sci. 2020;10(11). https://doi.org/10.3390/brainsci10110840.
Alberich S, Fernandez-Sevillano J, Gonzalez-Ortega I, Usall J, Saenz M, Gonzalez-Fraile E, et al. A systematic review of sex-based differences in effectiveness and adverse effects of clozapine. Psychiatry Res. 2019;280: 112506. https://doi.org/10.1016/j.psychres.2019.112506.
Ozdemir AK, Pak SC, Canan F, Gecici O, Kuloglu M, Gucer MK. Paliperidone palmitate use in pregnancy in a woman with schizophrenia. Arch Womens Ment Health. 2015;18(5):739–40. https://doi.org/10.1007/s00737-014-0496-6.
Ballester-Gracia I, Perez-Almarcha M, Galvez-Llompart A, Hernandez-Viadel M. Use of long acting injectable aripiprazole before and through pregnancy in bipolar disorder: a case report. BMC Pharmacol Toxicol. 2019;20(1):52. https://doi.org/10.1186/s40360-019-0330-x.
Teodorescu A, Ifteni P, Moga MA, Burtea V, Bigiu N. Dilemma of treating schizophrenia during pregnancy: a case series and a review of literature. BMC Psychiatry. 2017;17(1):311. https://doi.org/10.1186/s12888-017-1475-z.
Kim SW, Kim KM, Kim JM, Shin IS, Shin HY, Yang SJ, et al. Use of long-acting injectable risperidone before and throughout pregnancy in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 2007;31(2):543–5.
Munk-Olsen T, Liu X, Viktorin A, Brown HK, Di Florio A, D’Onofrio BM, et al. Maternal and infant outcomes associated with lithium use in pregnancy: an international collaborative meta-analysis of six cohort studies. Lancet Psychiatry. 2018;5(8):644–52. https://doi.org/10.1016/S2215-0366(18)30180-9.
Clark CT. Psychotropic drug use in perinatal women with bipolar disorder. Semin Perinatol. 2020;44(3): 151230. https://doi.org/10.1016/j.semperi.2020.151230.
• Molenaar NM, Poels EMP, Robakis T, Wesseloo R, Bergink V. Management of lithium dosing around delivery: an observational study. Bipolar Disord. 2021;23(1):49–54. https://doi.org/10.1111/bdi.12955. This study provides some evidence to consider continuing a mother’s lithium dose throughout the birth, challenging the standard practice of stopping lithium for the immediate period during the labor and birth/C-section of the baby.
Marxer CA, Ruegg S, Rauch MS, Panchaud A, Meier CR, Spoendlin J. A review of the evidence on the risk of congenital malformations and neurodevelopmental disorders in association with antiseizure medications during pregnancy. Expert Opin Drug Saf. 2021:1–13. https://doi.org/10.1080/14740338.2021.1943355.
Baldessarini RJ, Tondo L, Vazquez GH. Pharmacological treatment of adult bipolar disorder. Mol Psychiatry. 2019;24(2):198–217. https://doi.org/10.1038/s41380-018-0044-2.
Cohen JM, Huybrechts KF, Patorno E, Desai RJ, Mogun H, Bateman BT, et al. Anticonvulsant mood stabilizer and lithium use and risk of adverse pregnancy outcomes. J Clin Psychiatry. 2019;80(4). https://doi.org/10.4088/JCP.18m12572.
• Sprague J, Wisner KL, Bogen DL. Pharmacotherapy for depression and bipolar disorder during lactation: a framework to aid decision making. Semin Perinatol. 2020;44(3): 151224. https://doi.org/10.1016/j.semperi.2020.151224. Provides an innovative framework for consideration and discussion of risks of breastfeeding while on medications for bipolar disorder and depression.
Pacchiarotti I, Leon-Caballero J, Murru A, Verdolini N, Furio MA, Pancheri C, et al. Mood stabilizers and antipsychotics during breastfeeding: focus on bipolar disorder. Eur Neuropsychopharmacol. 2016;26(10):1562–78. https://doi.org/10.1016/j.euroneuro.2016.08.008.
Fortinguerra F, Clavenna A, Bonati M. Psychotropic drug use during breastfeeding: a review of the evidence. Pediatrics. 2009;124(4):e547–56. https://doi.org/10.1542/peds.2009-0326.
Lithium. Drugs and lactation database (LactMed). Bethesda (MD): National Library of Medicine (US); 2006.
Newmark RL, Bogen DL, Wisner KL, Isaac M, Ciolino JD, Clark CT. Risk-benefit assessment of infant exposure to lithium through breast milk: a systematic review of the literature. Int Rev Psychiatry. 2019;31(3):295–304. https://doi.org/10.1080/09540261.2019.1586657.
Kacirova I, Grundmann M, Brozmanova H. Valproic acid concentrations in nursing mothers, mature milk, and breastfed infants in monotherapy and combination therapy. Epilepsy Behav. 2019;95:112–6. https://doi.org/10.1016/j.yebeh.2019.04.002.
Uguz F. A new safety scoring system for the use of psychotropic drugs during lactation. Am J Ther. 2021;28(1):e118–26. https://doi.org/10.1097/MJT.0000000000000909.
Rose S, Dotters-Katz SK, Kuller JA. Electroconvulsive therapy in pregnancy: safety, best practices, and barriers to care. Obstet Gynecol Surv. 2020;75(3):199–203. https://doi.org/10.1097/OGX.0000000000000763.
Xiong W, Lopez R, Cristancho P. Transcranial magnetic stimulation in the treatment of peripartum bipolar depression: a case report. Braz J Psychiatry. 2018;40(3):344–5. https://doi.org/10.1590/1516-4446-2018-0037.
Clark R, Tluczek A, Brown R. A mother-infant therapy group model for postpartum depression. Infant Ment Health J. 2008;29(5):514–36. https://doi.org/10.1002/imhj.20189.
Forman DR, O’Hara MW, Stuart S, Gorman LL, Larsen KE, Coy KC. Effective treatment for postpartum depression is not sufficient to improve the developing mother-child relationship. Dev Psychopathol. 2007;19(2):585–602. https://doi.org/10.1017/S0954579407070289.
Bright KS, Charrois EM, Mughal MK, Wajid A, McNeil D, Stuart S, et al. Interpersonal psychotherapy to reduce psychological distress in perinatal women: a systematic review. Int J Environ Res Public Health. 2020;17(22). https://doi.org/10.3390/ijerph17228421.
Dimidjian S, Goodman SH, Felder JN, Gallop R, Brown AP, Beck A. Staying well during pregnancy and the postpartum: a pilot randomized trial of mindfulness-based cognitive therapy for the prevention of depressive relapse/recurrence. J Consult Clin Psychol. 2016;84(2):134–45. https://doi.org/10.1037/ccp0000068.
Muzik M, Rosenblum KL, Alfafara EA, Schuster MM, Miller NM, Waddell RM, et al. Mom Power: preliminary outcomes of a group intervention to improve mental health and parenting among high-risk mothers. Arch Womens Ment Health. 2015;18(3):507–21. https://doi.org/10.1007/s00737-014-0490-z.
Funding
Dr. Batt is receiving funding from the Hearst Foundation. Dr. Olsavsky is receiving funding from the Developmental Psychobiology Endowment Fund (University of Colorado), American Academy of Child and Adolescent Psychiatry Pilot Award, the National Institute of Mental Health Loan Repayment Program, and the National Institute on Drug Abuse/American Academy of Child and Adolescent Psychiatry K12 Career Development Award (K12DA000357 – PI Gray).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
Dr. Olsavsky’s spouse is employed by Thermo Fisher Scientific.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This article is part of the Topical collection on Reproductive Psychiatry and Women's Health
Rights and permissions
About this article
Cite this article
Batt, M.M., Olsavsky, A.K., Dardar, S. et al. Course of Illness and Treatment Updates for Bipolar Disorder in the Perinatal Period. Curr Psychiatry Rep 24, 111–120 (2022). https://doi.org/10.1007/s11920-022-01323-6
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11920-022-01323-6